drugset / Trial / NCT06765928
Selinexor Combined With Venetoclax Maintenance Therapy After Allo-HSCT
NaSingle-groupOpen-labelTreatment
Summary
A multicenter, single-arm clinical study of evaluate the efficacy and safety of selinexor combined with venetoclax as maintenance therapy following allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia patients.
Timeline
- Start
- 2025-01-01
- Primary completion
- 2026-01-01
- Completion
- 2028-01-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Selinexor | Other / unclassified | — | — |
| Subject | Venetoclax | Small molecule | — | — |